Not Yet RecruitingACTRN12624000970549
Official study titleDelivery and evaluation of the engagement of a health and wellbeing programme for young people experiencing psychosis
This study isn't recruiting yet.
In New ZealandSchizophreniaInterventional studyAges 16–24
- Countries
- New Zealand
- Sponsor
- University of Otago
Not Yet RecruitingACTRN12624000357550
Official study titleHybrid: Integrating Virtual Reality, Neurofeedback and Cognitive Behaviour Therapy for Treatment of Hearing Voices in Young People Experiencing Psychosis
This study isn't recruiting yet.
Multiple locations, including ParkvilleSchizophreniaInterventional studyAges 15–25
- Countries
- Australia
- Sponsor
- Barnaby Nelson
Not Yet RecruitingACTRN12618001107213
Official study titleKeep it Real: A web-based program for psychotic-like experiences and cannabis use
A Randomised Controlled Trial, Testing the Efficacy of the “Keep it Real” Website
This study isn't recruiting yet.
In AustraliaSchizophreniaInterventional studyAges 16–25
- Countries
- Australia
- Sponsor
- University of Queensland
RecruitingEUCTR 2017-001170-42
This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.
Multiple locations, including GdańskSchizophreniaHistorical research record
- Countries
- Poland
- Sponsor
- SyneuRx International (Taiwan) Corp
RecruitingEUCTR 2022-000054-28
This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.
Multiple locations, including AugsburgSchizophreniaHistorical research record
- Countries
- Germany
- Sponsor
- Klinikum der Universität München
RecruitingEUCTR 2022-001582-12
This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.
Multiple locations, including BarcelonaSchizophreniaHistorical research record
- Countries
- Spain
- Sponsor
- Consorcio Centro de Investigacion Biomedica en Red (CIBER)
RecruitingNCT04478838
Official study title"Re-examining Maintenance Antipsychotic Treatment in Schizophrenia: "Extended" Antipsychotic Dosing"
In TorontoSchizophreniaMedication studyAges 18+
- Countries
- Canada
- Sponsor
- Centre for Addiction and Mental Health (Hospital / academic medical center)
RecruitingNCT07369154
What is this study about?This study evaluates the safety of LB-102 for people with schizophrenia.
Multiple locations, including ChandlerSchizophreniaMedication studyAges 18–65
- Countries
- United States
- Sponsor
- LB Pharmaceuticals Inc.
RecruitingNCT07615426
What is this study about?This study evaluates the safety of Aticaprant for people with schizophrenia.
Multiple locations, including Garden GroveSchizophreniaMedication studyAges 18–60
- Countries
- United States
- Sponsor
- Janssen Research & Development, LLC
RecruitingNCT07221877
Official study titleA 12-month Open-label, Phase 4 Multicenter Safety Study to Evaluate the Effect of KarXT on Voiding Dynamics and Urological Safety
Multiple locations, including Little RockSchizophreniaMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Bristol-Myers Squibb (Pharmaceutical company)
RecruitingNCT04414215
About this title
Cognitive Training for Emotion Regulation in Psychotic Disorders
Read the official source — NCT04414215Official study titleCognitive Training for Emotion Regulation in Psychotic Disorders
In AthensSchizophreniaBehavioural studyAges 18–60
- Countries
- United States
- Sponsor
- University of Georgia
RecruitingNCT04370730
About this title
Dimensional and Developmental Profiles of Psychosis in Children and Adolescents
Read the official source — NCT04370730Official study titleDimensional and Developmental Approach to Psychotic Episodes in Children and Adolescents: Impact on Clinical Management
In ParisSchizophreniaInterventional studyAges 7–20
- Countries
- France
- Sponsor
- Assistance Publique - Hôpitaux de Paris